Trifluoperazine reduces cuprizone-induced demyelination via targeting Nrf2 and IKB in mice
- 1 October 2021
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 909, 174432
Abstract
No abstract availableKeywords
Funding Information
- Kermanshah University of Medical Sciences (3010023)
This publication has 73 references indexed in Scilit:
- Neuroprotective Effects of Psychotropic Drugs in Huntington’s DiseaseInternational Journal of Molecular Sciences, 2013
- Activation of Nrf2-antioxidant signaling attenuates NFκB-inflammatory response and elicits apoptosisBiochemical Pharmacology, 2008
- Analysis of nitrite and nitrate in biological fluids by assays based on the Griess reaction: Appraisal of the Griess reaction in the l-arginine/nitric oxide area of researchJournal of Chromatography B, 2007
- Behavioral deficits in the cuprizone-induced murine model of demyelination/remyelinationToxicology Letters, 2007
- The Neurotoxic Effect of Cuprizone on Oligodendrocytes Depends on the Presence of Pro-inflammatory Cytokines Secreted by MicrogliaNeurochemical Research, 2006
- Trifluoperazine, an orally available clinically used drug, disrupts opioid antinociceptive toleranceNeuroscience Letters, 2006
- The Calmodulin Antagonist Trifluoperazine in Transient Focal Brain Ischemia in RatsStroke, 1997
- Expression of inducible nitric oxide synthase causes delayed neurotoxicity in primary mixed neuronal-glial cortical culturesNeuropharmacology, 1994
- NMDA-dependent superoxide production and neurotoxicityNature, 1993
- Influence of psychotropic drugs and β-diethylaminoethyl-diphenylpropylacetate (SKF 525-A) on mescaline-induced behavior and on tissue levels of mescaline in miceBiochemical Pharmacology, 1976